Lamdong Pharmaceutical JSC (HNX:LDP)

HNX:LDP Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	146,079	148,053	129,572	201,980	66,056	476,368
Market Cap Growth	-4.17%	14.26%	-35.85%	205.77%	-86.13%	180.37%
Enterprise Value	177,593	188,307	161,439	252,243	161,527	488,077
Last Close Price	7800.00	11100.00	10200.00	15900.00	5200.00	37500.00
PE Ratio	4.27	5.18	18.73	-	-	12.58
PS Ratio	0.60	0.61	0.59	1.09	0.35	2.94
PB Ratio	0.76	0.77	1.31	2.19	0.59	3.11
P/TBV Ratio	0.76	0.77	1.31	2.19	0.59	3.12
P/FCF Ratio	-	-	22.21	33.79	-	22.27
P/OCF Ratio	36.38	42.89	14.78	33.46	-	16.38
EV/Sales Ratio	0.73	0.77	0.74	1.36	0.86	3.02
EV/EBITDA Ratio	7.90	8.15	7.98	-	-	-
EV/EBIT Ratio	10.28	10.79	12.16	-	-	-
EV/FCF Ratio	-3.02	-	27.67	42.20	-	22.82
Debt / Equity Ratio	0.32	0.30	0.55	0.71	0.63	0.21
Debt / EBITDA Ratio	2.72	2.46	2.72	-	-	-
Debt / FCF Ratio	-	-	9.43	11.04	-	1.51
Net Debt / Equity Ratio	0.16	0.19	0.38	0.50	0.47	-0.21
Net Debt / EBITDA Ratio	1.40	1.56	1.87	-11.13	-3.20	4.08
Net Debt / FCF Ratio	-0.54	-0.61	6.49	7.65	-1.12	-1.54
Asset Turnover	0.94	0.95	1.09	0.88	0.84	-
Inventory Turnover	3.12	3.12	3.54	3.18	2.71	-
Quick Ratio	0.61	0.58	0.43	0.43	0.45	1.52
Current Ratio	2.22	2.19	1.48	1.39	1.40	2.47
Return on Equity (ROE)	19.46%	19.64%	7.22%	-19.63%	-29.26%	-
Return on Assets (ROA)	4.17%	4.24%	4.13%	-3.65%	-7.12%	-
Return on Invested Capital (ROIC)	7.47%	9.53%	9.65%	-8.15%	-17.73%	-12.77%
Return on Capital Employed (ROCE)	8.90%	9.00%	13.10%	-13.10%	-22.10%	-12.60%
Earnings Yield	19.50%	19.29%	5.34%	-9.95%	-58.88%	7.95%
FCF Yield	-40.27%	-40.25%	4.50%	2.96%	-70.73%	4.49%
Buyback Yield / Dilution	-22.64%	-10.75%	0.00%	-0.01%	0.02%	-62.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.